Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 5:36 pm Sale | 2024-12-31 | 13G | Iveda Solutions, Inc. IVDA | Armistice Capital, LLC | 139,603 4.990% | -96,660 (-40.91%) | Filing History |
| 2025-02-14 5:36 pm Purchase | 2024-12-31 | 13G | Iterum Therapeutics plc ITRM | Armistice Capital, LLC | 1,445,158 4.990% | 105,158 (+7.85%) | Filing History |
| 2025-02-14 5:35 pm Purchase | 2024-12-31 | 13G | Inhibikase Therapeutics, Inc. IKT | Armistice Capital, LLC | 3,529,006 4.990% | 2,770,121 (+365.03%) | Filing History |
| 2025-02-14 5:35 pm Purchase | 2024-12-31 | 13G | T Stamp Inc. IDAI | Armistice Capital, LLC | 1,397,878 4.990% | 1,397,878 (New Position) | Filing History |
| 2025-02-14 5:35 pm Sale | 2024-12-31 | 13G | GeoVax Labs, Inc. GOVX | Armistice Capital, LLC | 495,589 4.990% | -450,548 (-47.62%) | Filing History |
| 2025-02-14 5:34 pm Purchase | 2024-12-31 | 13G | Eledon Pharmaceuticals, Inc. ELDN | Armistice Capital, LLC | 3,137,553 4.990% | 773,553 (+32.72%) | Filing History |
| 2025-02-14 5:33 pm Sale | 2024-12-31 | 13G | Clene Inc. CLNN | Armistice Capital, LLC | 419,101 4.990% | -280,899 (-40.13%) | Filing History |
| 2025-02-14 5:33 pm Sale | 2024-12-31 | 13G | Can-Fite BioPharma Ltd. CANF | Armistice Capital, LLC | 22,021 4.990% | -11,905 (-35.09%) | Filing History |
| 2025-02-14 5:32 pm Purchase | 2024-12-31 | 13G | Banzai International, Inc. BNZI | Armistice Capital, LLC | 30,910 4.990% | 14,807 (+91.95%) | Filing History |
| 2025-02-14 5:31 pm Purchase | 2024-12-31 | 13G | Mustang Bio, Inc. MBIO | Armistice Capital, LLC | 5,106,287 9.990% | 5,106,287 (New Position) | Filing History |
| 2025-02-14 5:30 pm Purchase | 2024-12-31 | 13G | Kura Oncology, Inc. KURA | Armistice Capital, LLC | 5,800,000 7.460% | 5,800,000 (New Position) | Filing History |
| 2025-02-14 5:30 pm Purchase | 2024-12-31 | 13G | Professional Diversity Network, Inc. IPDN | Armistice Capital, LLC | 133,418 9.990% | 133,418 (New Position) | Filing History |
| 2025-02-14 5:29 pm Purchase | 2024-12-31 | 13G | Intensity Therapeutics, Inc. INTS | Armistice Capital, LLC | 1,126,868 8.130% | 1,126,868 (New Position) | Filing History |
| 2025-02-14 5:28 pm Purchase | 2024-12-31 | 13G | Globus Maritime Limited GLBS | Armistice Capital, LLC | 1,200,000 5.510% | 1,200,000 (New Position) | Filing History |
| 2025-02-14 5:28 pm Sale | 2024-12-31 | 13G | Draganfly Inc. DPRO | Armistice Capital, LLC | 480,794 8.860% | -1,114,414 (-69.86%) | Filing History |
| 2025-02-14 5:27 pm Purchase | 2024-12-31 | 13G | BioXcel Therapeutics, Inc. BTAI | Armistice Capital, LLC | 4,997,275 9.990% | 4,997,275 (New Position) | Filing History |
| 2025-02-14 5:26 pm Purchase | 2024-12-31 | 13G | Bio-Path Holdings, Inc. BPTH | Armistice Capital, LLC | 613,798 9.990% | 613,798 (New Position) | Filing History |
| 2025-02-14 5:25 pm Sale | 2024-12-31 | 13G | BIO-key International, Inc. BKYI | Armistice Capital, LLC | 164,235 4.990% | -85,765 (-34.31%) | Filing History |
| 2025-02-14 5:25 pm Sale | 2024-12-31 | 13G | Brainstorm Cell Therapeutics Inc. BCLI | Armistice Capital, LLC | 299,548 4.990% | -7,784,398 (-96.29%) | Filing History |
| 2025-02-14 5:24 pm Purchase | 2024-12-31 | 13G | Voyager Therapeutics, Inc. VYGR | Armistice Capital, LLC | 5,396,000 9.880% | 196,000 (+3.77%) | Filing History |